| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | mitotic spindle midzone assembly | 9.01e-05 | 11 | 27 | 2 | GO:0051256 | |
| GeneOntologyBiologicalProcess | mitotic spindle elongation | 1.08e-04 | 12 | 27 | 2 | GO:0000022 | |
| GeneOntologyBiologicalProcess | spindle midzone assembly | 1.49e-04 | 14 | 27 | 2 | GO:0051255 | |
| GeneOntologyBiologicalProcess | spindle elongation | 1.49e-04 | 14 | 27 | 2 | GO:0051231 | |
| GeneOntologyBiologicalProcess | mitotic sister chromatid segregation | 1.58e-04 | 212 | 27 | 4 | GO:0000070 | |
| GeneOntologyCellularComponent | nuclear matrix | 3.48e-05 | 140 | 28 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear periphery | 7.59e-05 | 171 | 28 | 4 | GO:0034399 | |
| GeneOntologyCellularComponent | midbody | 2.08e-04 | 222 | 28 | 4 | GO:0030496 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 1.19e-03 | 157 | 28 | 3 | GO:1902554 | |
| GeneOntologyCellularComponent | protein kinase complex | 1.49e-03 | 170 | 28 | 3 | GO:1902911 | |
| GeneOntologyCellularComponent | cyclin-dependent protein kinase holoenzyme complex | 3.02e-03 | 61 | 28 | 2 | GO:0000307 | |
| MousePheno | increased dendritic spine number | 3.68e-06 | 3 | 16 | 2 | MP:0021019 | |
| MousePheno | postnatal growth retardation | 2.67e-05 | 881 | 16 | 7 | MP:0001732 | |
| MousePheno | impaired conditioning behavior | 3.05e-05 | 165 | 16 | 4 | MP:0012317 | |
| MousePheno | abnormal postnatal growth | 3.22e-05 | 907 | 16 | 7 | MP:0001731 | |
| MousePheno | behavioral developmental delay | 3.43e-05 | 8 | 16 | 2 | MP:0021165 | |
| MousePheno | abnormal dendritic spine number | 5.50e-05 | 10 | 16 | 2 | MP:0021017 | |
| MousePheno | impaired contextual conditioning behavior | 1.91e-04 | 101 | 16 | 3 | MP:0009454 | |
| MousePheno | abnormal learning/memory/conditioning | 2.36e-04 | 1239 | 16 | 7 | MP:0002063 | |
| MousePheno | abnormal cognition | 2.44e-04 | 1246 | 16 | 7 | MP:0014114 | |
| MousePheno | abnormal common lymphocyte progenitor cell morphology | 2.55e-04 | 21 | 16 | 2 | MP:0008249 | |
| MousePheno | impaired long-term object recognition memory | 4.56e-04 | 28 | 16 | 2 | MP:0014367 | |
| Domain | ULD | 2.01e-06 | 2 | 27 | 2 | PF16534 | |
| Domain | ULD | 2.01e-06 | 2 | 27 | 2 | IPR032392 | |
| Domain | CUTL | 2.01e-06 | 2 | 27 | 2 | IPR032355 | |
| Domain | CUTL | 2.01e-06 | 2 | 27 | 2 | PF16557 | |
| Domain | CUT | 4.21e-05 | 7 | 27 | 2 | PF02376 | |
| Domain | CUT_dom | 4.21e-05 | 7 | 27 | 2 | IPR003350 | |
| Domain | CUT | 4.21e-05 | 7 | 27 | 2 | SM01109 | |
| Domain | CUT | 4.21e-05 | 7 | 27 | 2 | PS51042 | |
| Domain | Cyclin_L/T | 5.61e-05 | 8 | 27 | 2 | IPR015429 | |
| Domain | Cyclin_C-dom | 2.70e-04 | 17 | 27 | 2 | IPR004367 | |
| Domain | Cyclin_C | 2.70e-04 | 17 | 27 | 2 | PF02984 | |
| Domain | Cyclin_C | 2.70e-04 | 17 | 27 | 2 | SM01332 | |
| Domain | - | 6.91e-04 | 27 | 27 | 2 | 1.10.260.40 | |
| Domain | CYCLINS | 7.43e-04 | 28 | 27 | 2 | PS00292 | |
| Domain | Lambda_DNA-bd_dom | 7.98e-04 | 29 | 27 | 2 | IPR010982 | |
| Domain | Cyclin_N | 1.03e-03 | 33 | 27 | 2 | IPR006671 | |
| Domain | Cyclin_N | 1.03e-03 | 33 | 27 | 2 | PF00134 | |
| Domain | CYCLIN | 1.37e-03 | 38 | 27 | 2 | SM00385 | |
| Domain | - | 1.52e-03 | 40 | 27 | 2 | 1.10.472.10 | |
| Domain | Kinesin_motor_CS | 1.59e-03 | 41 | 27 | 2 | IPR019821 | |
| Domain | Cyclin-like | 1.75e-03 | 43 | 27 | 2 | IPR013763 | |
| Domain | Kinesin-like_fam | 1.75e-03 | 43 | 27 | 2 | IPR027640 | |
| Domain | KINESIN_MOTOR_1 | 1.83e-03 | 44 | 27 | 2 | PS00411 | |
| Domain | - | 1.83e-03 | 44 | 27 | 2 | 3.40.850.10 | |
| Domain | Kinesin_motor_dom | 1.83e-03 | 44 | 27 | 2 | IPR001752 | |
| Domain | Kinesin | 1.83e-03 | 44 | 27 | 2 | PF00225 | |
| Domain | KISc | 1.83e-03 | 44 | 27 | 2 | SM00129 | |
| Domain | KINESIN_MOTOR_2 | 1.83e-03 | 44 | 27 | 2 | PS50067 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25543122 | ||
| Pubmed | KIF4 regulates neuronal morphology and seizure susceptibility via the PARP1 signaling pathway. | 6.25e-07 | 2 | 28 | 2 | 36482480 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 21565503 | ||
| Pubmed | Whole genome expression microarray reveals novel roles for Kif4 in monocyte/macrophage cells. | 6.25e-07 | 2 | 28 | 2 | 31486502 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 10773663 | ||
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 7929562 | ||
| Pubmed | The multiple functions of kinesin-4 family motor protein KIF4 and its clinical potential. | 6.25e-07 | 2 | 28 | 2 | 30081192 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 31616463 | ||
| Pubmed | Structural basis for the ATP-induced isomerization of kinesin. | 6.25e-07 | 2 | 28 | 2 | 23500491 | |
| Pubmed | Chromokinesin Kif4 promotes proper anaphase in mouse oocyte meiosis. | 6.25e-07 | 2 | 28 | 2 | 31067151 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 28350061 | ||
| Pubmed | Satb1 and Satb2 are dispensable for X chromosome inactivation in mice. | 6.25e-07 | 2 | 28 | 2 | 23079603 | |
| Pubmed | ATM suppresses SATB1-induced malignant progression in breast epithelial cells. | 6.25e-07 | 2 | 28 | 2 | 23251624 | |
| Pubmed | 6.25e-07 | 2 | 28 | 2 | 25323550 | ||
| Pubmed | Binding of murine leukemia virus Gag polyproteins to KIF4, a microtubule-based motor protein. | 6.25e-07 | 2 | 28 | 2 | 9658142 | |
| Pubmed | Cellular motor protein KIF-4 associates with retroviral Gag. | 6.25e-07 | 2 | 28 | 2 | 10559369 | |
| Pubmed | Kif4 interacts with EB1 and stabilizes microtubules downstream of Rho-mDia in migrating fibroblasts. | 6.25e-07 | 2 | 28 | 2 | 24658398 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 18216018 | ||
| Pubmed | Identification of the human homologue of mouse KIF4, a kinesin superfamily motor protein. | 1.87e-06 | 3 | 28 | 2 | 10978527 | |
| Pubmed | KIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activity. | 1.87e-06 | 3 | 28 | 2 | 16630823 | |
| Pubmed | CDK13/CDC2L5 interacts with L-type cyclins and regulates alternative splicing. | 1.87e-06 | 3 | 28 | 2 | 17261272 | |
| Pubmed | SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer. | 1.87e-06 | 3 | 28 | 2 | 26701851 | |
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 34545188 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 35579738 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 16890532 | ||
| Pubmed | 1.87e-06 | 3 | 28 | 2 | 34073140 | ||
| Pubmed | Characterization of cyclin L1 as an immobile component of the splicing factor compartment. | 1.87e-06 | 3 | 28 | 2 | 17494991 | |
| Pubmed | KIF4 mediates anterograde translocation and positioning of ribosomal constituents to axons. | 1.87e-06 | 3 | 28 | 2 | 19158085 | |
| Pubmed | Increased expression of a 58-kDa protein kinase leads to changes in the CHO cell cycle. | 3.75e-06 | 4 | 28 | 2 | 2217177 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 18684836 | ||
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 24436071 | ||
| Pubmed | USP1 deubiquitinates ID proteins to preserve a mesenchymal stem cell program in osteosarcoma. | 3.75e-06 | 4 | 28 | 2 | 21925315 | |
| Pubmed | 3.75e-06 | 4 | 28 | 2 | 28125646 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 11683997 | ||
| Pubmed | 6.24e-06 | 5 | 28 | 2 | 17516030 | ||
| Pubmed | Satb1 and Satb2 regulate embryonic stem cell differentiation and Nanog expression. | 6.24e-06 | 5 | 28 | 2 | 19933152 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 23362347 | ||
| Pubmed | The chromatin modifier Satb1 regulates cell fate through Fgf signalling in the early mouse embryo. | 1.31e-05 | 7 | 28 | 2 | 28289135 | |
| Pubmed | 1.31e-05 | 7 | 28 | 2 | 1447303 | ||
| Pubmed | Genetic mapping in the mouse of Kif4, a gene encoding a kinesin-like motor protein. | 1.31e-05 | 7 | 28 | 2 | 9196009 | |
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 14623875 | ||
| Pubmed | 2.24e-05 | 9 | 28 | 2 | 23202124 | ||
| Pubmed | Long noncoding RNA lncKdm2b is required for ILC3 maintenance by initiation of Zfp292 expression. | 2.24e-05 | 9 | 28 | 2 | 28319097 | |
| Pubmed | Gene expression and cell identity controlled by anaphase-promoting complex. | 2.26e-05 | 68 | 28 | 3 | 32076268 | |
| Pubmed | 2.80e-05 | 10 | 28 | 2 | 29101321 | ||
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 15843429 | ||
| Pubmed | 3.42e-05 | 11 | 28 | 2 | 20493910 | ||
| Pubmed | Temporal patterning of apical progenitors and their daughter neurons in the developing neocortex. | 3.97e-05 | 82 | 28 | 3 | 31073041 | |
| Pubmed | Ovol1 regulates meiotic pachytene progression during spermatogenesis by repressing Id2 expression. | 4.10e-05 | 12 | 28 | 2 | 15716349 | |
| Pubmed | 6.52e-05 | 15 | 28 | 2 | 26290337 | ||
| Pubmed | Satb2 is a postmitotic determinant for upper-layer neuron specification in the neocortex. | 6.52e-05 | 15 | 28 | 2 | 18255031 | |
| Pubmed | Stalled replication forks within heterochromatin require ATRX for protection. | 7.45e-05 | 16 | 28 | 2 | 27171262 | |
| Pubmed | The UAS thioredoxin-like domain of UBXN7 regulates E3 ubiquitin ligase activity of RNF111/Arkadia. | 7.61e-05 | 102 | 28 | 3 | 37024974 | |
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 26509897 | ||
| Pubmed | 9.49e-05 | 18 | 28 | 2 | 28689657 | ||
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 31911655 | ||
| Pubmed | 1.18e-04 | 20 | 28 | 2 | 15733084 | ||
| Pubmed | Snf2h Drives Chromatin Remodeling to Prime Upper Layer Cortical Neuron Development. | 1.30e-04 | 21 | 28 | 2 | 31680852 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | 1.49e-04 | 1038 | 28 | 6 | 26673895 | |
| Pubmed | Neurogenesis requires TopBP1 to prevent catastrophic replicative DNA damage in early progenitors. | 1.71e-04 | 24 | 28 | 2 | 22522401 | |
| Pubmed | Zbtb20 modulates the sequential generation of neuronal layers in developing cortex. | 1.85e-04 | 25 | 28 | 2 | 27282384 | |
| Pubmed | ATR maintains select progenitors during nervous system development. | 1.85e-04 | 25 | 28 | 2 | 22266795 | |
| Pubmed | 2.17e-04 | 27 | 28 | 2 | 33787491 | ||
| Pubmed | 2.33e-04 | 28 | 28 | 2 | 29365100 | ||
| Pubmed | Regulation of archicortical arealization by the transcription factor Zbtb20. | 2.33e-04 | 28 | 28 | 2 | 22689450 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | 2.66e-04 | 1155 | 28 | 6 | 20360068 | |
| Pubmed | 2.98e-04 | 162 | 28 | 3 | 15174051 | ||
| Pubmed | 3.05e-04 | 32 | 28 | 2 | 19571125 | ||
| Pubmed | 3.25e-04 | 33 | 28 | 2 | 32758484 | ||
| Pubmed | 3.66e-04 | 35 | 28 | 2 | 22991445 | ||
| Pubmed | 3.66e-04 | 35 | 28 | 2 | 20943929 | ||
| Pubmed | Identification of Novel Nuclear Factor of Activated T Cell (NFAT)-associated Proteins in T Cells. | 3.93e-04 | 178 | 28 | 3 | 27637333 | |
| Pubmed | All kinesin superfamily protein, KIF, genes in mouse and human. | 4.09e-04 | 37 | 28 | 2 | 11416179 | |
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 4.47e-04 | 186 | 28 | 3 | 33637726 | |
| Pubmed | Receptor-mediated clustering of FIP200 bypasses the role of LC3 lipidation in autophagy. | 4.58e-04 | 454 | 28 | 4 | 33226137 | |
| Pubmed | Genetic variations strongly influence phenotypic outcome in the mouse retina. | 6.33e-04 | 46 | 28 | 2 | 21779340 | |
| Pubmed | 6.89e-04 | 48 | 28 | 2 | 17274640 | ||
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | 7.23e-04 | 910 | 28 | 5 | 36736316 | |
| Pubmed | A conserved acetylation switch enables pharmacological control of tubby-like protein stability. | 7.57e-04 | 223 | 28 | 3 | 33187986 | |
| Pubmed | Systematic subcellular localization of novel proteins identified by large-scale cDNA sequencing. | 7.77e-04 | 523 | 28 | 4 | 11256614 | |
| Cytoband | 12q24.11 | 1.87e-04 | 33 | 28 | 2 | 12q24.11 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr3q27 | 2.78e-03 | 128 | 28 | 2 | chr3q27 | |
| GeneFamily | CUT class homeoboxes and pseudogenes | 3.75e-05 | 9 | 19 | 2 | 527 | |
| GeneFamily | Cyclins | 3.89e-04 | 28 | 19 | 2 | 473 | |
| GeneFamily | Kinesins|Pleckstrin homology domain containing | 1.05e-03 | 46 | 19 | 2 | 622 | |
| Coexpression | EGFR_UP.V1_DN | 4.65e-05 | 196 | 27 | 4 | M2633 | |
| Coexpression | GSE22886_UNSTIM_VS_IL15_STIM_NKCELL_UP | 4.65e-05 | 196 | 27 | 4 | M4532 | |
| Coexpression | GSE12845_IGD_NEG_BLOOD_VS_NAIVE_TONSIL_BCELL_DN | 4.74e-05 | 197 | 27 | 4 | M3193 | |
| Coexpression | GSE17721_0.5H_VS_8H_GARDIQUIMOD_BMDC_DN | 4.93e-05 | 199 | 27 | 4 | M4142 | |
| Coexpression | GSE25123_ROSIGLITAZONE_VS_IL4_AND_ROSIGLITAZONE_STIM_MACROPHAGE_DAY10_UP | 4.93e-05 | 199 | 27 | 4 | M7967 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.59e-06 | 196 | 28 | 4 | c4e7133c609bcbc48c4947ea0aa1a7d9d7251b04 | |
| ToppCell | mild-MAIT|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.00e-06 | 199 | 28 | 4 | cbe1fb6d2c5fca7a1baf1ad20afcdf8e8e11bd84 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Naive_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 7.00e-06 | 199 | 28 | 4 | 885bc902b6e2af0b61e452c4154160cd3f1cf98e | |
| ToppCell | control-gd_T|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.14e-06 | 200 | 28 | 4 | b188f2acb9bd4f5f1ad4c3d3ddb9a55854a8b74b | |
| ToppCell | Dividing_Macrophages-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 1.08e-04 | 148 | 28 | 3 | 66b51aa6690bf8fbc90fa5a6f86191703e2d5046 | |
| ToppCell | 390C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-04 | 153 | 28 | 3 | 764fb5e5fa028c137b8ea65dcd5e4ec9b22191e9 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.26e-04 | 156 | 28 | 3 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Posterior_cortex|World / BrainAtlas - Mouse McCarroll V32 | 1.33e-04 | 159 | 28 | 3 | 18e9fe2efbe0bca7c3990f3b12b6f549e2c1263a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.43e-04 | 163 | 28 | 3 | 3f434015c0cbefb31eeda133c34f75384c5f7e22 | |
| ToppCell | PND10-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.46e-04 | 164 | 28 | 3 | ae09e5aabd1347b865474255e7411c04f63efb3b | |
| ToppCell | normal-na-Lymphocytic_NK-NK_bright-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 1.46e-04 | 164 | 28 | 3 | b5a91f2cbfad9a2bc38aea576085a37865df955d | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.48e-04 | 165 | 28 | 3 | 9f6f3a614ac614488e9f59cf2805467ff075ccca | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.48e-04 | 165 | 28 | 3 | eec2d327c94832d1390314c93ef6a2be4648478b | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.51e-04 | 166 | 28 | 3 | 2642544070564debe2deb2938d2c33997bf5ef02 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.54e-04 | 167 | 28 | 3 | 50c29ea660bf07b890e4ac1a1985d0761d863dee | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.54e-04 | 167 | 28 | 3 | 754e6412d3b9cc0b126e59593df2f5956b4712ef | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.56e-04 | 168 | 28 | 3 | d35944fd9fea9934ce1e76b2b35d48e2300cca61 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 170 | 28 | 3 | 2d5e56eee0c3ce75a9641cc14dee0e0807141c32 | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_B-B-B_G2M|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.62e-04 | 170 | 28 | 3 | e08a6c5ac34c456da8c7318f104e06fca585be1f | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi-Sox9_Epi_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.65e-04 | 171 | 28 | 3 | 621f9da0bfa09c86fc89fd26919403e94cd56d2b | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.65e-04 | 171 | 28 | 3 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-mature_NK_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.71e-04 | 173 | 28 | 3 | 36a471576a9d2325066bb14c2f2cd89c67b92915 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-T_mait|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.79e-04 | 176 | 28 | 3 | 003076f1a983409ddf31b9c19e61c1facdd72566 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c05-FOS|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.82e-04 | 177 | 28 | 3 | 3d1b142aa2bd18df14816abaca356596b297394e | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 178 | 28 | 3 | 15a99080e9f669572ab6d82934f324e6714846c1 | |
| ToppCell | facs-Marrow-Granulocytes-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 178 | 28 | 3 | 200308e109abb7e6f8816a6f8cce6d56862d4098 | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_T-T_NK-CD8_T_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.92e-04 | 180 | 28 | 3 | 5273aa2b939b5c640d708d6ca1812550dff5ec0f | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | 566249e04dd491e6287ad2101b7b1ab11031ed8b | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-04 | 181 | 28 | 3 | db9528dc7cb0230e4c36cb27da69102c588c7ee9 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.95e-04 | 181 | 28 | 3 | 9c4f9abb9335da2b07644bca8faff1baa1bb9f5b | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | c075756cd4bb484ede1be2bcdb9eac60eab0573a | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Cycling_T|Liver / Manually curated celltypes from each tissue | 1.98e-04 | 182 | 28 | 3 | 81557cdc88777f3bd4e1dd18a760b08fc29122ef | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.98e-04 | 182 | 28 | 3 | 9025178ede571e3808d4657ad4892152f336c9b4 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic-innate_lymphoid_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.98e-04 | 182 | 28 | 3 | b86690c109cdc16844a6cd2216c1bf2bf28efd45 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.04e-04 | 184 | 28 | 3 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | URO-Lymphocyte-T_NK-T_NK_proliferative|URO / Disease, Lineage and Cell Type | 2.08e-04 | 185 | 28 | 3 | 0ae9c646679c69a553eda670aef0e0495feb0286 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.11e-04 | 186 | 28 | 3 | fc0b488c201a32d829047b58460297df2818b45d | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-innate_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.11e-04 | 186 | 28 | 3 | 855c2e5a8a6cf94c7de31982e0e2416f924439d3 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-lymphocytic-innate_lymphocytic-mature_NK_T_cell|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.14e-04 | 187 | 28 | 3 | 6981b856187a2e689260ecb7d0a1193a374ee9b9 | |
| ToppCell | metastatic_Brain-T/NK_cells-CD4+_Th|T/NK_cells / Location, Cell class and cell subclass | 2.18e-04 | 188 | 28 | 3 | a23591d917e1fea2b850d5a363001bc698578fa0 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-T_NK-T_NK_proliferative|Multiple_Sclerosis / Disease, Lineage and Cell Type | 2.18e-04 | 188 | 28 | 3 | 6c05797a5d0635d89ffcf4aca52178687129ccb4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 189 | 28 | 3 | e9df7ecd36bee1fedce23bb188c68a94fa60462c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 189 | 28 | 3 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like|bone_marrow / Manually curated celltypes from each tissue | 2.21e-04 | 189 | 28 | 3 | ac2995e599f3d1813218479dc515b1d612c0ef8b | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.21e-04 | 189 | 28 | 3 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK-NK_bright|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.21e-04 | 189 | 28 | 3 | 3e148accffc6ab249fb0dff7f3bf5a7fff9da773 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.21e-04 | 189 | 28 | 3 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.28e-04 | 191 | 28 | 3 | 7a4fe96989f72159385270c712342ba3e1ca6fc3 | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 89eb4e30052d0d4a2952157ca743291900ce8de2 | |
| ToppCell | Control-Lymphoid_T/NK-NK_CD56bright|Control / Disease group, lineage and cell class | 2.28e-04 | 191 | 28 | 3 | e842f29bc03ed6734b2a7b975e7830a498f2743c | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic-T_cell|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | 0bf575eba311745fb75f9523f7fc81f73848e25d | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.28e-04 | 191 | 28 | 3 | f1935e8f8467a2bc30588b7f2cc3b94e9c83b268 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.28e-04 | 191 | 28 | 3 | c023ca893ceae19b54967096f6e2588dc39fa268 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 191 | 28 | 3 | 696921a4f160b6b55698652488ed781e855e5e51 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.28e-04 | 191 | 28 | 3 | d9a6f61fcda4f5352488f7f55cb9b57aeacc717f | |
| ToppCell | facs-Trachea-nan-3m-Lymphocytic-nan|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.28e-04 | 191 | 28 | 3 | c57df363e3a6e61d2bdca1955330f1899b964267 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-NK_cell-NK_CD56bright-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.28e-04 | 191 | 28 | 3 | 1161e465c50c2071764279e01cf08b1048cce0e3 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_Invariant-Inducer-like-MAIT|bone_marrow / Manually curated celltypes from each tissue | 2.28e-04 | 191 | 28 | 3 | 7a28905ad504979497836e87df81d529e675ce78 | |
| ToppCell | 3'_v3-bone_marrow|World / Manually curated celltypes from each tissue | 2.28e-04 | 191 | 28 | 3 | 7b759831f1b1c8575c31f67d0d9eb11c6a833cf3 | |
| ToppCell | (3)_Macrophage_Dividing|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.28e-04 | 191 | 28 | 3 | b42f0b89bb94fd43786ff50f1caeb3ebfbbb43fd | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.32e-04 | 192 | 28 | 3 | 284955fec5103194d416320f41fa4d87c7efc4fb | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 192 | 28 | 3 | 0d3b2b9cd586a4adbc3755563dd50b140227c287 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell-CD4+_T_cell_(ISG_high)|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.32e-04 | 192 | 28 | 3 | 35557254738844c27ffcd00f3287fbcc0a4d0f3b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.32e-04 | 192 | 28 | 3 | ef8970e5389bd55c1624cd6dd01a7ca7abaa8950 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.32e-04 | 192 | 28 | 3 | ad2e0f35d50fe4e6977eba8a7a2bd990f6946305 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 2.32e-04 | 192 | 28 | 3 | ab88ea7723f0fa3b39611981c043445f27425404 | |
| ToppCell | PBMC-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.32e-04 | 192 | 28 | 3 | 67f50e5b1d449923002dc5b5d0c4d32c523034d3 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.35e-04 | 193 | 28 | 3 | 6436d3bfce02d137b76e5c4c8b2fe27974c57c99 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.35e-04 | 193 | 28 | 3 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Cycling_T|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.35e-04 | 193 | 28 | 3 | 81e6240cffb094b2aa3684fd0889b6497f47c4f0 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.35e-04 | 193 | 28 | 3 | 3cde93bbfc1ae6fb586ae6b7aaa6ed8b5eee28a4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.35e-04 | 193 | 28 | 3 | d755dc6de4fbd4d8f5d8a88aac497e7b9e8b89de | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.35e-04 | 193 | 28 | 3 | a594f89a18273797506287d9e22f72abe53e4920 | |
| ToppCell | Control-CD8+_T_naive|Control / Disease condition and Cell class | 2.35e-04 | 193 | 28 | 3 | 627d345baf1940218c61907305705298e473dbab | |
| ToppCell | Control-Lymphocyte-T_NK|Control / Disease, Lineage and Cell Type | 2.35e-04 | 193 | 28 | 3 | eb8b8f6e52fd140fbacf3d6776458c6fc355e120 | |
| ToppCell | Healthy/Control-CD4+_T_naive|Healthy/Control / Disease group and Cell class | 2.35e-04 | 193 | 28 | 3 | f5face746df3517c86d72e31ba8f1b78c4c6b481 | |
| ToppCell | Healthy/Control-CD4+_T_naive|World / Disease group and Cell class | 2.35e-04 | 193 | 28 | 3 | 6218e6cbe44d92bb98d42ef2f5e18ab7a683b100 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD8+_T-CD8+_T_naive|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.35e-04 | 193 | 28 | 3 | d371403b51281a6e37652fa8dc1b2dd81d2ab371 | |
| ToppCell | Int-URO-Lymphocyte-T_NK-NK|Int-URO / Disease, Lineage and Cell Type | 2.35e-04 | 193 | 28 | 3 | 5c7942f630fc69374df34ee3602ad973b6ced17a | |
| ToppCell | COVID-19_Convalescent-PLT_4|COVID-19_Convalescent / Disease Group and Platelet Clusters | 2.39e-04 | 194 | 28 | 3 | ce1fad4e76a87f0c35e430ed1f2262395df882fd | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-NK|Leuk-UTI / Disease, Lineage and Cell Type | 2.39e-04 | 194 | 28 | 3 | 36afc4e48d267be3b8aa1e33fad043bcd54c6bc5 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.39e-04 | 194 | 28 | 3 | 0abca32c3547a45cebab0bd69c1f7a0002deaa80 | |
| ToppCell | systemic_lupus_erythematosus-treated-Lymphocytic_NK-natural_killer_cell|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.39e-04 | 194 | 28 | 3 | a3a81638b55cb5fc08fe83c8b88f68d49b87e6cb | |
| ToppCell | COVID-19_Severe-Lymphoid_T/NK-CD8+_T_naive|COVID-19_Severe / Disease group, lineage and cell class | 2.39e-04 | 194 | 28 | 3 | 6aeedfdb2b526913937eea978ddcbab8be4e49a6 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.39e-04 | 194 | 28 | 3 | a7bfc535546d3c1a4e0cbcfeb7da816b34303350 | |
| ToppCell | severe_COVID-19-CD4+_T_naive|severe_COVID-19 / disease group, cell group and cell class (v2) | 2.39e-04 | 194 | 28 | 3 | 4b86f3cc173ea779399d5b3598b45b25f60a4395 | |
| ToppCell | tumor_Lung|World / Location, Cell class and cell subclass | 2.39e-04 | 194 | 28 | 3 | 7e6b8a30f8d08252ad3f1df826d6f7c0ba997c2c | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.39e-04 | 194 | 28 | 3 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | Immune-T_lymphocyte|World / Lineage, Cell type, age group and donor | 2.39e-04 | 194 | 28 | 3 | f47fa18c87b35a3960557f8169ff7830dd6ecb80 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-naive_thymus-derived_CD4-positive,_alpha-beta_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.42e-04 | 195 | 28 | 3 | 4e114f6399863406bd87220dea7fb7dfd08824bd | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_NK|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 2.42e-04 | 195 | 28 | 3 | 609732e83ab7fc3ba7dace66f5a17e46557fd6d1 | |
| ToppCell | T/NK_cells-CD8+_Naive_T_cell|World / Lineage and Cell class | 2.42e-04 | 195 | 28 | 3 | 43f11068beea076e9caeb1572215c3f65c9308e1 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.42e-04 | 195 | 28 | 3 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.46e-04 | 196 | 28 | 3 | 0f3c7fd450aaa1f866b8558692534c0ea2a34e75 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.46e-04 | 196 | 28 | 3 | e4c76e7ad68455e51fe93ce588bcec9383f8654b | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-04 | 196 | 28 | 3 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | PBMC-Severe-Lymphocyte-T/NK-CD8+_T|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.46e-04 | 196 | 28 | 3 | 4e1f8828413896ab8a4ec92a89d6789e8e37e05a | |
| ToppCell | Control-Lymphocyte-T_NK-NK|Control / Disease, Lineage and Cell Type | 2.46e-04 | 196 | 28 | 3 | 65838fddc920cdcecefe823f3ce1c95a7e50e82b | |
| ToppCell | (3)_MNP-(3)_Macrophage_Dividing|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.50e-04 | 197 | 28 | 3 | 048bc4f8fd5d4f394e2384700640f72042336597 | |
| Drug | AC1L9STC | 8.74e-06 | 4 | 28 | 2 | CID000455431 | |
| Drug | 12-O-acetylphorbol-13-decanoate | 8.74e-06 | 4 | 28 | 2 | CID000124027 | |
| Drug | 12-O-tetradecanoylphorbol 13,20-diacetate | 8.74e-06 | 4 | 28 | 2 | CID000499948 | |
| Drug | AC1L4A6Q | 8.74e-06 | 4 | 28 | 2 | CID000182041 | |
| Drug | Silver Nitrate | 1.32e-05 | 119 | 28 | 4 | ctd:D012835 | |
| Drug | chelirubine | 2.18e-05 | 6 | 28 | 2 | CID000161243 | |
| Drug | norcyclizine | 4.07e-05 | 8 | 28 | 2 | CID000070048 | |
| Drug | Methoxy-6-harmalan [3589-73-9]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 8.91e-05 | 194 | 28 | 4 | 2893_UP | |
| Drug | Antipyrine, 4-hydroxy [1672-63-5]; Up 200; 19.6uM; HL60; HG-U133A | 9.46e-05 | 197 | 28 | 4 | 1997_UP | |
| Drug | AC1L2HAX | 9.55e-05 | 12 | 28 | 2 | CID000020942 | |
| Drug | Pepstatin A [26305-03-3]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 9.65e-05 | 198 | 28 | 4 | 4790_DN | |
| Drug | Danazol [17230-88-5]; Up 200; 11.8uM; PC3; HG-U133A | 9.84e-05 | 199 | 28 | 4 | 1954_UP | |
| Drug | trioxane | 1.13e-04 | 13 | 28 | 2 | CID000008081 | |
| Disease | Intellectual Disability | 6.92e-04 | 447 | 27 | 4 | C3714756 | |
| Disease | Small cell carcinoma of lung | 1.12e-03 | 54 | 27 | 2 | C0149925 | |
| Disease | Colorectal Neoplasms | 2.03e-03 | 277 | 27 | 3 | C0009404 | |
| Disease | Colorectal Carcinoma | 3.61e-03 | 702 | 27 | 4 | C0009402 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LIIYNLLTIVEMLHK | 861 | O60566 | |
| LEVKQIIHMLREYLE | 236 | Q6NXT1 | |
| YILNSMIIIIHLVEV | 191 | P30988 | |
| FAKYIEMHVIVEKQL | 176 | Q99965 | |
| PHKIIVMYLQVLECE | 201 | Q9UK58 | |
| ITVIVQKMLEYLHQS | 406 | Q9UPM8 | |
| EVLKRNHMQYEIVIK | 166 | P19827 | |
| LQKHGLEVIYMIELI | 196 | Q58FG0 | |
| KEVIIELFQLQIYIH | 276 | Q13315 | |
| KIINIVEVMNRHEYL | 151 | Q9BSB4 | |
| VHEILQAAMYVQLIE | 101 | Q96M94 | |
| IELYTHLPVMKQLVQ | 111 | Q9UHW5 | |
| PHKIIVMYLQVLECE | 196 | Q96S94 | |
| VEQLMYIKEDLIIPH | 246 | Q14320 | |
| VRMEQQHQEKVLYLL | 921 | O95239 | |
| VRMEQQHQEKVLYLV | 921 | Q2VIQ3 | |
| KEQKSIVIMVHIYED | 176 | Q13371 | |
| VQYEMKRKQIEHLIQ | 356 | Q8NF91 | |
| ILIEREVLMQKYIHL | 136 | O14827 | |
| EVLMQKYIHLVQIVE | 141 | O14827 | |
| KMEILQHVIDYILDL | 61 | Q02363 | |
| DMLQDVYHVVTLKIQ | 141 | Q9UPW6 | |
| VEYQQRIVDILLKVM | 806 | Q8N3P4 | |
| MLQDVYHVVTLKIQL | 156 | Q01826 | |
| LQVRKVMEHVYEKII | 591 | Q8TAF3 | |
| HQVVVLTLEVNMYIK | 56 | P35504 | |
| IIIHAVIQEYMLDKI | 91 | Q15629 | |
| EVVMNVVHQLAALYI | 156 | Q2M389 | |
| TVMVVVIVCLLNHYK | 76 | O15165 |